Related Experiment Video
Updated: Mar 21, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.8K
Actein Inhibits Cell Proliferation and Migration in Human Osteosarcoma
Zhi Chen1, Jingdong Wu2, Qinghao Guo2
1Department of Emergency Medicine, Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (mainland).
Summary
Actein effectively inhibits osteosarcoma cell growth and spread by inducing apoptosis. This natural compound shows promise as a novel therapeutic agent for osteosarcoma treatment.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Osteosarcoma is a prevalent malignant bone cancer with high mortality in pediatric and adolescent populations.
- Current chemotherapies offer limited efficacy, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the anti-cancer effects of actein in osteosarcoma.
- To elucidate the mechanisms underlying actein's action on osteosarcoma cells.
Main Methods:
- Cell viability, colony formation, cell cycle, and apoptosis assays were performed on osteosarcoma cell lines (143B and U2OS).
- Caspase activity and cell migration/invasion were assessed following actein treatment.
Main Results:
- Actein significantly inhibited osteosarcoma cell viability and colony formation in a dose- and time-dependent manner.
- Actein induced G0/G1 cell cycle arrest and apoptosis, evidenced by increased caspase-3 and caspase-9 activities.
- Actein treatment suppressed the migration and invasion capabilities of osteosarcoma cells.
Conclusions:
- Actein demonstrates potent anti-tumor effects in osteosarcoma by promoting apoptosis and inhibiting proliferation, migration, and invasion.
- Actein represents a potential therapeutic candidate for osteosarcoma treatment.
More Related Videos
Related Concept Videos
02:34Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
02:34Inhibition of CDK Activity
5.6K
5.6K
01:35Cancer Cell Migration through Invadopodia
3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K